Table 1: Demographic and baseline characteristics of the patients.

CharacteristicsTreatment group
( )
Control group
( )
value

Age (years) 0.346
Male104 (76.5)104 (77.0)1.000
Height (cm) 0.516
Weight (kg) 0.824
Body mass index (kg/m2) 0.775
Course of illness (years) 0.450
HBV DNA (lgcopies/mL) 0.456
Grade of necroinflammatory*0.600
 G228 (68.3)29 (74.4)
 G310 (24.4)9 (23.1)
 G43 (7.3)1 (2.6)
Stage of fibrosis*0.621
 S00 (0.0)1 (2.6)
 S112 (29.3)7 (17.9)
 S217 (41.5)19 (48.7)
 S39 (22.0)10 (25.6)
 S43 (7.3)2 (5.1)
Prior resistance by genotypic analysis*0 (0)0 (0)1.000

A total of 80 patients had adequate baseline and liver-biopsy specimens at week 52 (41 patients in treatment group and 39 in control group). Values in parentheses are percentages unless indicated otherwise; value was presented as mean ± standard deviation.